These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 15218693

  • 1. Analysis of the microvasculature and tissue type ratios in normal vs. benign and malignant breast tissue.
    Wells WA, Daghlian CP, Tosteson TD, Grove MR, Poplack SP, Knowlton-Soho S, Paulsen KD.
    Anal Quant Cytol Histol; 2004 Jun; 26(3):166-74. PubMed ID: 15218693
    [Abstract] [Full Text] [Related]

  • 2. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.
    Weind KL, Maier CF, Rutt BK, Moussa M.
    Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579
    [Abstract] [Full Text] [Related]

  • 3. Correlation of microvessel parameters in invasive ductal carcinoma of the breast and fibroadenomas: a morphometric study.
    Boruah D, Bhatia JK, Rai A, Srinivas V, Nijhawan VS.
    Ann Diagn Pathol; 2016 Dec; 25():72-78. PubMed ID: 27806851
    [Abstract] [Full Text] [Related]

  • 4. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Silverberg SG.
    Anticancer Res; 1997 Dec; 17(3C):2001-7. PubMed ID: 9216657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
    Koshiishi T, Isomoto I, Nakamura K, Kajiwara Y, Izawa K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
    [Abstract] [Full Text] [Related]

  • 9. PLASMINOGEN AND ANGIOSTATIN LEVELS IN FEMALE BENIGN BREAST LESIONS.
    Tykhomyrov AA, Vovchuk IL, Grinenko TV.
    Ukr Biochem J; 2015 Jul; 87(5):103-12. PubMed ID: 26717601
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identifying Two Common Types of Breast Benign Diseases Based on Multiphoton Microscopy.
    Wu Y, Lin Y, Lian Y, Lin P, Wang S, Fu F, Wang C, Chen J.
    Scanning; 2018 Jul; 2018():3697063. PubMed ID: 29849858
    [Abstract] [Full Text] [Related]

  • 14. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
    Schneider P, Piper S, Schmitz CH, Schreiter NF, Volkwein N, Lüdemann L, Malzahn U, Poellinger A.
    Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Measuring microvascular density in tumors by digital dissection.
    Samoszuk M, Leonor L, Espinoza F, Carpenter PM, Nalcioglu O, Su MY.
    Anal Quant Cytol Histol; 2002 Feb; 24(1):15-22. PubMed ID: 11865945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.